protein

APLP-2 Protein, Human (HEK293, His)

HY-P700659

20 μg;50 μg;100 μg

125;250;400 USD

APLP-2 Protein, Human (HEK293, His)

proteins

HEK293

20 μg;50 μg;100 μg

125;250;400 USD

APLP-2, potentially involved in hemostasis regulation, exhibits inhibitory effects on coagulation factors. Its soluble form may interact with G-protein signaling pathways and bind to DNA. APLP-2 inhibits various proteases and modulates the nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains. It interacts with proteins like CPEB1, DAB2, APBB2/FE65L, and APBB3/FE65L2, suggesting diverse cellular roles. APLP-2 Protein, Human (HEK293, His) is the recombinant human-derived APLP-2 protein, expressed by HEK293 , with C-His labeled tag. The total length of APLP-2 Protein, Human (HEK293, His) is 661 a.a., with molecular weight of 85-100 kDa.

Human

APLP-2, a multifunctional protein, is implicated in the regulation of hemostasis, with its soluble form demonstrating inhibitory properties towards coagulation factors. This protein may engage with cellular G-protein signaling pathways and exhibits binding to the DNA 5'-GTCACATG-3' (CDEI box). APLP-2 showcases diverse inhibitory activities, including trypsin, chymotrypsin, plasmin, factor XIA, and plasma and glandular kallikrein. Moreover, it modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts. In its molecular interactions, APLP-2 engages with CPEB1 and interacts with DAB2 via its NPXY motif, with this interaction being influenced by tyrosine phosphorylation. Additionally, APLP-2 associates with APBB2/FE65L and APBB3/FE65L2, underscoring its involvement in intricate cellular networks.

APPH; CDEBP; CDEI box-binding; APPL2; YWK-II;

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. Normally 8% trehalose is added as protectant before lyophilization.

Room temperature in continental US; may vary elsewhere.